The Analyst Verdict: Addus HomeCare In The Eyes Of 8 Experts
Throughout the last three months, 8 analysts have evaluated Addus HomeCare (NASDAQ:ADUS), offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 4 | 0 | 1 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 2 | 0 | 0 | 0 |
| 2M Ago | 2 | 1 | 0 | 1 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Addus HomeCare, revealing an average target of $117.38, a high estimate of $130.00, and a low estimate of $83.00. Witnessing a positive shift, the current average has risen by 4.93% from the previous average price target of $111.86.
Decoding Analyst Ratings: A Detailed Look
A comprehensive examination of how financial experts perceive Addus HomeCare is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Ryan Langston | TD Cowen | Raises | Buy | $128.00 | $119.00 |
| Michael Wiederhorn | Oppenheimer | Raises | Outperform | $130.00 | $118.00 |
| Scott Fidel | Stephens & Co. | Raises | Overweight | $128.00 | $120.00 |
| Ryan Langston | TD Cowen | Raises | Buy | $119.00 | $105.00 |
| Scott Fidel | Stephens & Co. | Maintains | Overweight | $115.00 | - |
| Joanna Gajuk | B of A Securities | Raises | Buy | $118.00 | $115.00 |
| Andrew Mok | Barclays | Lowers | Underweight | $83.00 | $88.00 |
| Michael Wiederhorn | Oppenheimer | Maintains | Outperform | $118.00 | $118.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Addus HomeCare. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Addus HomeCare compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Addus HomeCare's stock. This analysis reveals shifts in analysts' expectations over time.
Capture valuable insights into Addus HomeCare's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Addus HomeCare analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
About Addus HomeCare
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
Addus HomeCare: A Financial Overview
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Addus HomeCare's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 11.58% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Addus HomeCare's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 5.64%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.21%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Addus HomeCare's ROA stands out, surpassing industry averages. With an impressive ROA of 1.55%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.21, Addus HomeCare adopts a prudent financial strategy, indicating a balanced approach to debt management.
What Are Analyst Ratings?
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.